Inflammatory Brain Disorders
Conference 2021
Registration is closed.
The Inflammatory Brain Disorders Conference 2021 featured nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who will present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders.
The intended audience is pediatric and adult physicians. Both generalists as well as specialists will find the conference valuable to their practices. The conference is designed for pediatricians, family physicians, psychiatrists, rheumatologists, immunologists, neurologists, and infectious disease physicians. Though the conference is designed for physicians, physician assistants and nurse practitioners will find the series valuable to their practices as well.
Conference Schedule
May 13, 2021
Neuropsychiatric Presentation in Pediatric COVID-19 Patients Associated with Anti-neural Autoantibodies
Keynote: Sam Pleasure, MD, PhD
Glenn W. Johnson, Jr. Memorial Endowed Chair
Professor, Department of Neurology, University of California, San Francisco (UCSF)
Director Neuroscience Graduate Program, UCSF
Joined by Claire Johns, MD,
Pediatric Neurology Resident/Fellow, UCSF
Metabolic and Mitochondrial Considerations in Neuropsychiatric Deteriorations
Richard Frye, MD, PhD
Chief of the Division of Neurodevelopmental Disorders at Phoenix Children’s Hospital
Professor, Department of Neurology, Barrow Neurological Institute at Phoenix Children’s Professor, Pediatric Neurology, The Mayo Clinic Alix School of Medicine, Scottsdale, AZ
Rheumatology and Psychiatry: What We Can Learn From Overlapping Conditions
Jennifer Frankovich, MD
Clinical Professor of Pediatrics
Stanford University School of Medicine, Division of Allergy, Immunology, Rheumatology
Co-Director, Stanford Children’s Immune Behavioral Health Clinic
Director, Stanford Immune Behavioral Health Research Program
Autoantibody Discovery in Psychotic Spectrum Disorders
Christopher Bartley, MD, PhD
Immunopsychiatrist in the Department of Psychiatry and Behavioral Sciences
University of California, San Francisco (UCSF)
A Neurologist’s Perspective on PANS: Case Studies
Hrissanthi (Chris) Ikonomidou, MD, PhD
Chief, Section of Pediatric Neurology, University of Wisconsin American Family Children’s Hospital
Faculty, University of Wisconsin School of Medicine and Public Health
Plasmapheresis in Treatment of PANS
Wei Zhao, MD, PhD
Professor and Chief, Division of Allergy and Immunology
Virginia Commonwealth University
The Role of the Adaptive Immunity and Genetic Risk Factors in Vascular and Neuronal Dysfunction in Post-Infectious Autoimmune Encephalitis
Dritan Agalliu, PhD
Associate Professor of Pathology and Cell Biology in Neurology
Columbia University
Immunogenetic Variation in PANS and Neuroinflammatory Disease
Jill Hollenbach, PhD, MPH
Associate Professor, Departmeent of Neurology
University of California, San Francisco
Antibodies in Children with PANDAS Bind To AND Inhibit Specific Interneurons in The Basal Ganglia
Chris Pittinger, MD, PhD
Professor of Psychiatry in Yale Child Study Center
Disordered Eating in PANS
Cynthia Kapphahn, MD, MPH
Medical Director, Eating Disorders Program
Lucile Packard Children’s Hospital, Stanford
Clinical Professor, Division of Adolescent Medicine
Stanford University School of Medicine
Immunophenotypes of Monocytes in PANS
Elizabeth Mellins, MD
Professor of Pediatrics, Pediatric Rheumatologist and Molecular Immunologist
Stanford University School of Medicine
Preliminary Findings from the International PANS Registry Epidemiology Study
Erin Masterson, PhD, MPH
Epidemiologist, University of Washington, School of Public Health
Neuropsychiatric Presentation in Pediatric COVID-19 Patients Associated with Anti-neural Autoantibodies (with Dr. Pleasure)
Claire Johns, MD
Pediatric Resident/Fellow, University of California, San Francisco
Closing Remarks: Vision for an International Research Collaboration to Study Neuroimmune Disorders (Non-CME)
Carlos Bustamante, PhD
Professor of Biomedical Data Science, Genetics, and Biology
Professor of Genetics and (by courtesy) Biology, Stanford University School of Medicine
Founding Director, Stanford Center for Computational, Evolutionary, and Human Genomics
May 14, 2021
A Pediatrician’s Perspective on Treating Mild to Moderate PANS
Andrew Baumel, MD
Pediatrician, Framingham Pediatrics
Clinical Work up and Treatment of Rheumatological Diseases That Have Psychiatric Co-Morbidities
Ruy Carrasco, MD
Director, Pediatric Rheumatology Consultants of Austin
Clues From The Clinical Exam
Theresa Willett, MD, PhD
Clinical Assistant Professor, Pediatrics – Immunology, Allergy
Medical Director, SCH Immune Behavioral Health Clinic
Stanford University School of Medicine
The Link Between Infectious Diseases and Neuroimmune Disorders
Hayley Gans, MD
Clinical Professor, Pediatrics—Infectious Diseases
Stanford University School of Medicine
Psychiatric Medication Management in Inflammatory Psychiatric Disease With a Focus on PANS
Margo Thienemann, MD
Clinical Professor of Psychiatry
Stanford University School of Medicine
Neuropsychiatric Symptoms in Pediatric Multiple Sclerosis
Cynthia Wang, MD
Pediatric Neurologist
Assistant Professor, University of Texas, Southwestern Medical Center